Xcopri 100 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9CY3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,136
Award facts
- Contract value 100% obligated
- $5,136.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order contract by the Defense Logistics Agency (DLA) for the supply of Xcopri 100 mg tablets (30-count units) with a ceiling value of $5,136.21. The contract was awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, utilizing firm fixed-price pricing with no set-aside designation. This delivery order represents a competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that serves as the primary mechanism for supplying pharmaceuticals and medical supplies to Department of Defense healthcare systems worldwide.
The Xcopri delivery order falls within AmerisourceBergen's extensive pharmaceutical portfolio delivered to federal military and veteran healthcare systems. As a major pharmaceutical distributor, the company maintains a comprehensive supply capability across multiple therapeutic domains, including specialty medications, branded and generic drugs, and medical devices. The DLA Medical Supply Chain relies on AmerisourceBergen as a critical vendor to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through its flexible contract vehicle designed to meet diverse federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F9CY3?
SPE2DR26F9CY3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9CY3 worth?
The government has obligated $5,136 on SPE2DR26F9CY3.
Is contract SPE2DR26F9CY3 an order under another contract?
Yes. SPE2DR26F9CY3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9CY3 competed?
The extent of competition for SPE2DR26F9CY3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award